ReviewFrontiers in cellular neuroscience2020

Mesenchymal Stromal Cells' Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?

Inês Barros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.